HIGHLIGHTS
- who: Nida Iqbal from the Department of Medical Oncology, DrBR. A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences have published the Article: Imatinib: A Breakthrough of Targeted Therapy in Cancer, in the Journal: (JOURNAL) of 19/05/2014
- what: None of the studies showed any significant correlation with the expression and/or mutations in Imatinib sensitive tyrosine kinase with outcome or response. be considered as an alternative in some patients who progress on conventional therapy.
- how: This review discusses the clinical implications of Imatinib in various cancers.
SUMMARY . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.